Publications
476
Citations
21,756
Est. group size
—
Recurring co-author estimate
Active years
56
Publishing since 1971
Typically publishes in teams of ~7 · 36% small-team papers (≤3 authors) · across 61 venues
- Management of Thyroid Eye Disease: A Comparison Between Three Recent Clinical Guidelines
Ophthalmology and Therapy · 2026
- Thyroid Eye Disease (TED) Monocytes Express a Functional Thyrotropin Receptor and Express Increased IL-6 and IL-8: Possible Mechanistic Implications
Ophthalmic Plastic and Reconstructive Surgery · 2026
- HLA Associations Differ by Ethnicity and Aquaporin-4 Antibody Status in Patients With Neuromyelitis Optica Spectrum Disorders
Neurology Neuroimmunology & Neuroinflammation · 2026
- Safety profile of teprotumumab-trbw, the first and only FDA-approved treatment for thyroid-associated ophthalmopathy
Expert Opinion on Drug Safety · 2026
- Prognostic Biomarker Signature of Relapse in Neuromyelitis Optica Spectrum Disorders in the CIRCLES Observational Study
Neurology Neuroimmunology & Neuroinflammation · 2026
- Treatment of Hyperthyroidism in Graves' Disease Complicated by Thyroid Eye Disease
The Journal of Clinical Endocrinology & Metabolism · 2025
- Controversies Surrounding IGF-I Receptor Involvement in Thyroid-Associated Ophthalmopathy
Thyroid · 2025
- G Protein-coupled and Membrane Tyrosine Kinase Receptor Relationships Yield Therapeutic Opportunities
Endocrine Reviews · 2025
- Thyroid eye disease and the IGF-1 receptor
The Lancet Diabetes & Endocrinology · 2025
- Virtual consultation in kidney care: a mixed-methods study on a model for safe and effective integration into routine clinical care
BMJ Open · 2025
- Patient-reported quality of life and perceived disease burden in mexican patients with neuromyelitis optica spectrum disorder: a cross-sectional analysis
Multiple Sclerosis and Related Disorders · 2025
- SPHERES: innovative registry addressing the new era of neuromyelitis optica spectrum disorders (NMOSD) therapy
Multiple Sclerosis and Related Disorders · 2025
- Sex ratio and age of onset in AQP4 antibody-associated NMOSD: a review and meta-analysis
Journal of Neurology · 2024
- Long-Term Efficacy of Teprotumumab in Thyroid Eye Disease: Follow-Up Outcomes in Three Clinical Trials
Thyroid · 2024
- Glycemic Trends in Patients with Thyroid Eye Disease Treated with Teprotumumab in 3 Clinical Trials
Ophthalmology · 2024
- Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature×12
- Neurology Neuroimmunology & Neuroinflammation×11
- The Journal of Clinical Endocrinology & Metabolism×10
- Journal of the Endocrine Society×10
- Neurology×6
- Roshini Fernando
Medicine · University of Michigan
- Christopher Gappy
Medicine · University of Michigan
- Steven M. Archer
Medicine · University of Michigan
- Denise S. Kim
Medicine · University of Michigan
- Brittany A. Simmons
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile